PATENTS

 USPTO
Pat Num		TitleInventorsDate
110676518A4B2 nicotinic acetylcholine receptors with
reduced or increased nicotine sensitivity and transgenic mouse model for the same.		Caballero-Rivera; Daniel, Biaggi-
Labiosa; Nilza M, Aviles-Pagan; Emir, Lasalde-Dominicci; José A.		April 2016
29,650,627Site-directed RNA editingRosenthal; Joshua J. C., Montiel-Gonzalez; Maria FernandaMay 2017
310,106,572Supramolecular hacky sacks (SHS), method of synthesis and applications thereofRivera; Jose M, Negron; Luis MOct 2018
410,155,221High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition.Lasalde-Dominicci; Jose A., Quesada-Gonzalez;
Orestes, Rodriguez-Cordero; Josue, Baez-Pagan; Carlos		Dec 2018
510,358,475High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable compositionJose A. Lasalde-Dominicci, Orestes Quesada-Gonzalez, Josue Rodriguez-Cordero, Carlos Baez- PaganJuly 2019
610,597,462Anti-TLT-1 antibody and uses thereofWashington Anthony VMarch 2020
715/996,946High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable compositionJose A. Lasalde-DominicciApril 2022
April 1, 2022
High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition

Jose A. Lasalde-Dominicci

U.S. Patent No: Pending

June 9, 2020
A4B2 nicotinic acetylcholine receptors with reduced or increased nicotine sensitivity and transgenic mouse model for the same)

Caballero Rivera D, Biaggi-Labiosa NM, Avilez-Pagan E, Lasalde-Dominicci JA

U.S. Patent No: 10,676,518

March 24, 2020
ANTI-TLT-1 ANTIBODY AND USES THEREOF

Valance-Washington A, Ferrer-Acosta Y, Morales J, Reyes-Baez F

U.S. Patent No: 10,597,462

July 23, 2019
High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition

Lasalde-Dominicci; Jose A., Quesada-Gonzalez; Orestes, Rodriguez-Cordero, Josue, Baez-Pagan; Carlos

U. S. Patent No: 10, 358, 475

December 18, 2018
High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition

Lasalde-Dominicci; José A., Quesada-González; Orestes, Rodríguez-Cordero, Josué, Báez-Pagan; Carlos

U.S. Patent No: 10,155,221

October 23, 2018
Supramolecular hacky sacks (SHS), method of synthesis and applications thereof

Rivera JM, Negrón LM

U.S. Patent No: 10,106,572

May 16, 2017
Site-directed RNA editing

Rosenthal JJC, Montiel-González MF

U.S. Patent No: 9,650,627

PUBLICATIONS

October 1, 2015
Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C.

Figueroa CM, Morales-Cruz M, Suárez BN, Fernández JC, Molina AM, Quiñones CM, Griebenow K
J. Nanomedicine Nanotechnol. 2015; 6 (5): 1–9. DOI: 10.4172/2157-7439.1000316

September 1, 2015
Time-Dependent Effects of Ethanol on BK Channel Expression and Trafficking in Hippocampal Neurons.

Palacio S, Velázquez-Marrero C, Marrero HG, Seale GE, Yudowski GA, Treistman SN
Alcohol. Clin. Exp. Res. 2015; 39 (9): 1619–1631. DOI: 10.1111/acer.12808

September 1, 2015
Ethanol Effect on BK Channels is Modulated by Magnesium.

Marrero HG, Treistman SN, Lemos JR
Alcohol. Clin. Exp. Res. 2015; 39 (9): 1671–1679. DOI: 10.1111/acer.12821

September 1, 2015
Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.

Báez-Pagán CA, Delgado-Vélez M, Lasalde-Dominicci JA
J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol. 2015; 10 (3): 468–476. DOI:
10.1007/s11481-015-9601-5

August 1, 2015
Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.

Zhu H, Grajales-Reyes GE, Alicea-Vázquez V, Grajales-Reyes JG, Robinson K, Pytel P, Báez-Pagán
CA, Lasalde-Dominicci JA, Gomez CM
Exp. Neurol. 2015; 270 88–94. DOI: 10.1016/j.expneurol.2014.10.008

June 18, 2015
Histamine Immunoreactive Elements in the Central and Peripheral Nervous Systems of the Snail, Biomphalaria spp., Intermediate Host for Schistosoma mansoni.

Habib MR, Mohamed AH, Osman GY, Sharaf El-Din AT, Mossalem HS, Delgado N, Torres G,
Rolón-Martínez S, Miller MW, Croll RP,
PloS One. 2015; 10 (6): e0129800. DOI: 10.1371/journal.pone.0129800

June 10, 2015
Development of HAMLET-like Cytochrome c-Oleic Acid Nanoparticles for Cancer Therapy.

Delgado Y, Morales-Cruz M, Hernández-Román J, Hernández G, Griebenow K
J. Nanomedicine Nanotechnol. 2015; 6 (4): 1–8. DOI: 10.4172/2157-7439.1000303

June 1, 2015
Cytocompatibility of direct water synthesized cadmium selenide quantum dots in colo-205 cells.

Rodriguez-Torres MR, Velez C, Zayas B, Rivera O, Arslan Z, Gonzalez-Vega MN, Diaz-Diestra D,
Beltran-Huarac J, Morell G, Primera-Pedrozo OM
J. Nanoparticle Res. Interdiscip. Forum Nanoscale Sci. Technol. 2015; 17 (6): 1–11. DOI:
10.1007/s11051-015-3064-8

April 15, 2015
Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.

Martin I, Cabán-Hernández K, Figueroa-Santiago O, Espino AM
J. Immunol. Baltim. Md 1950. 2015; 194 (8): 3924–3936. DOI: 10.4049/jimmunol.1401182

April 1, 2015
The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes.

Barreto-Torres G, Hernandez JS, Jang S, Rodríguez-Muñoz AR, Torres-Ramos CA, Basnakian AG, Javadov S
Am. J. Physiol. Heart Circ. Physiol. 2015; 308 (7): H749-758. DOI: 10.1152/ajpheart.00414.2014

March 30, 2015
Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia.

West RJH, Lu Y, Marie B, Gao F-B, Sweeney ST
J. Cell Biol. 2015; 208 (7): 931–947. DOI: 10.1083/jcb.201404066

March 1, 2015
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury.

Salgado IK, Torrado AI, Santiago JM, Miranda JD
Neural Regen. Res. 2015; 10 (3): 385–390. DOI: 10.4103/1673-5374.153685

January 1, 2015
The cytotoxicity of BAMLET complexes is due to oleic acid and independent of the α-lactalbumin component.

Delgado Y, Morales-Cruz M, Figueroa CM, Hernández-Román J, Hernández G, Griebenow K
FEBS Open Bio. 2015; 5 (1): 397–404. DOI: 10.1016/j.fob.2015.04.010

December 15, 2014
Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue.

Rosas OR, Torrado AI, Santiago JM, Rodriguez AE, Salgado IK, Miranda JD
Neural Regen. Res. 2014; 9 (24): 2164–2173. DOI: 10.4103/1673-5374.147949

October 17, 2014
Large conductance voltage- and Ca2+-gated potassium (BK) channel β4 subunit influences sensitivity and tolerance to alcohol by altering its response to kinases.

Velázquez-Marrero C, Seale GE, Treistman SN, Martin GE
J. Biol. Chem. 2014; 289 (42): 29261–29272. DOI: 10.1074/jbc.M114.604306

PRESENTATIONS

Some of the presentations sponsored by COBRE and NIEF cores could be observed in this file:

Presentations Sponsored by COBRE